7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025
Conference
Event
-
March 17, 2025
genOway's presentation on Wednesday, March 26, 2025 | 4 p.m. EDT:
How to enhance predictability of Treg-directed therapies in preclinical models:
- Outlining genO-BRGSF-HIS mice: a CD34+-reconstituted model with functional human lymphoid and myeloid compartments without side effects
- Demonstrating the recruitment of human Treg cells to the affected area, as well as their activation status
- Showcasing T-dependent inflammatory diseases modelling in genO-BRGSF-HIS mice
7th Treg-Directed Therapies Summit 2025, Boston, MA, March 25-27, 2025
Get in touch
Let us know how we can help
Other news & events
Scientific excellence
From model design to experimental results
Tailor-made solutions adapted to scientific questions
Robust validation data on catalog models
Comprehensive dataset package
Generated with biopharma partners and in-house
Customer care
Scientific follow-up and advice along the project
Collaborative approach for problem solving and development of innovative models
Easy and fast access to models
Breeding facilities in US and Europe
Certified health status from professional breeders